Pages that link to "Q70264232"

The following pages link to Antipyrine kinetics in the elderly: prediction of age-related changes in benzodiazepine oxidizing capacity (Q70264232):

Displaying 35 items.

• Comparative pharmacokinetics of brotizolam and triazolam in healthy subjects (Q24542434) (← links)
• Oxaprozin pharmacokinetics in the elderly (Q24544096) (← links)
• Clinical Pharmacokinetics of the Newer Benzodiazepines (Q28261121) (← links)
• Disposition of clotiazepam: influence of age, sex, oral contraceptives, cimetidine, isoniazid and ethanol (Q28261411) (← links)
• Pharmacokinetics and therapeutic drug monitoring of gentamicin in the elderly (Q33770259) (← links)
• The disposition of antipyrine and its metabolites in young and elderly healthy volunteers (Q34416893) (← links)
• Relationship between the metabolism of antipyrine, hexobarbitone and theophylline in man as assessed by a 'cocktail' approach (Q34418061) (← links)
• Single dose pharmacokinetics and pharmacodynamics of oral loprazolam in the elderly (Q34446648) (← links)
• Responsiveness to oral diazepam in the elderly: relationship to total and free plasma concentrations (Q34446670) (← links)
• Reduced clearance of triazolam in old age: relation to antipyrine oxidizing capacity (Q34512316) (← links)
• Effect of age and liver cirrhosis on the pharmacokinetics of nitrazepam (Q34512330) (← links)
• Pharmacokinetics of brotizolam in the elderly (Q34513962) (← links)
• Interaction of propoxyphene with diazepam, alprazolam and lorazepam (Q34622454) (← links)
• Age-related changes in the hepatic pharmacology and toxicology of paracetamol (Q35101500) (← links)
• Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part II). (Q36538982) (← links)
• Newer aspects of drug therapy in the elderly (Q37943705) (← links)
• Hepatic drug metabolism and aging (Q38018026) (← links)
• Age-related changes in liver size and hepatic blood flow. The influence on drug metabolism in the elderly (Q39618055) (← links)
• Assessment of Methods to Identify Sources of Interindividual Pharmacokinetic Variations (Q40108050) (← links)
• Sex-Related Differences in Drug Disposition in Man (Q40179654) (← links)
• Drug dosage in the elderly. Is it rational? (Q40834286) (← links)
• Pharmacokinetic investigations in elderly patients. Clinical and ethical considerations (Q41186732) (← links)
• Anticonvulsant therapy in aged patients. Clinical pharmacokinetic considerations (Q41435526) (← links)
• Age-related changes in trimethadione oxidizing capacity (Q42285148) (← links)
• The effect of aging on the relationship between the cytochrome P450 2C19 genotype and omeprazole pharmacokinetics (Q46758734) (← links)
• Impairment of caffeine clearance by chronic use of low-dose oestrogen-containing oral contraceptives (Q49323100) (← links)
• Effect of age and gender on the activity of human hepatic CYP3A (Q51686918) (← links)
• Effect of antipyrine coadministration on the kinetics of acetaminophen and lidocaine (Q51777849) (← links)
• Antipyrine Pharmacokinetics in Women Receiving Conjugated Estrogens (Q68437539) (← links)
• Clearance of the antihistamine doxylamine. Reduced in elderly men but not in elderly women (Q69649331) (← links)
• [Benzodiazepines: significance of kinetics for therapy] (Q70431351) (← links)
• Close correlation of acetaminophen clearance with that of conjugated benzodiazepines but not oxidized benzodiazepines (Q71036733) (← links)
• Interindividual variations in drug disposition. Clinical implications and methods of investigation (Q71064667) (← links)
• Reduced single-dose clearance of clobazam in elderly men predicts increased multiple-dose accumulation (Q71704325) (← links)
• Correlation between in vivo antipyrine metabolite formation and theophylline metabolism in rats (Q86836795) (← links)